• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔灌洗细胞学检查对胆道癌的影响(KHBO1701):关西肝胆肿瘤研究组。

The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato-Biliary Oncology Group.

机构信息

Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.

Kansai Hepato-Biliary Oncology Group, Osaka, Japan.

出版信息

Cancer Rep (Hoboken). 2021 Apr;4(2):e1323. doi: 10.1002/cnr2.1323. Epub 2020 Dec 6.

DOI:10.1002/cnr2.1323
PMID:33283475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8451372/
Abstract

BACKGROUND

Only few studies in literature have analyzed the clinical effects of peritoneal lavage status in biliary tract cancers.

AIM

We aimed to assess the effect of cytology-positive peritoneal lavage on survival for patients with biliary tract cancer who underwent curative resection.

METHODS

The KHBO1701 study was a multi-institutional retrospective study that assessed the clinical effects of peritoneal lavage cytology in biliary tract cancers. Using clinicopathological data from 11 Japanese institutions, we compared long-term outcomes between patients with cytology-positive and cytology-negative peritoneal lavage.

RESULTS

Of 169 patients who underwent curative resection, 164 were cytology-negative, and five were cytology-positive. The incidence of portal invasion and preoperative carbohydrate antigen 19-9 levels were higher in the cytology-positive group than in the cytology-negative group. The incidence of peritoneal metastatic recurrence was also higher, and overall survival tended to be worse in the cytology-positive group. In contrast, recurrence-free survival was similar between the cytology-negative and cytology-positive groups.

CONCLUSIONS

The positive status of peritoneal lavage cytology could moderately affect the survival of patients with biliary tract cancers. Given that surgical resection is the only curative treatment option, it may be acceptable to resect biliary tract cancers without other non-curative factors, regardless of peritoneal lavage cytology status.

摘要

背景

仅有少数文献研究分析了胆道癌患者腹腔灌洗状况的临床效果。

目的

我们旨在评估细胞学阳性的腹腔灌洗对接受根治性切除术的胆道癌患者生存的影响。

方法

KHBO1701 研究是一项多机构回顾性研究,评估了腹腔灌洗细胞学在胆道癌中的临床效果。我们利用来自 11 家日本机构的临床病理数据,比较了细胞学阳性和细胞学阴性腹腔灌洗患者的长期预后。

结果

在接受根治性切除术的 169 例患者中,164 例为细胞学阴性,5 例为细胞学阳性。细胞学阳性组的门静脉侵犯和术前癌抗原 19-9 水平的发生率高于细胞学阴性组。细胞学阳性组的腹膜转移复发发生率也较高,总生存时间较差。相比之下,细胞学阴性组和细胞学阳性组的无复发生存率相似。

结论

腹腔灌洗细胞学阳性状态可能会适度影响胆道癌患者的生存。鉴于手术切除是唯一的根治性治疗选择,对于没有其他非根治性因素的胆道癌患者,可能可以接受切除,而无需考虑腹腔灌洗细胞学状态。

相似文献

1
The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato-Biliary Oncology Group.腹腔灌洗细胞学检查对胆道癌的影响(KHBO1701):关西肝胆肿瘤研究组。
Cancer Rep (Hoboken). 2021 Apr;4(2):e1323. doi: 10.1002/cnr2.1323. Epub 2020 Dec 6.
2
Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society.行胰腺切除术的可切除性胰腺导管腺癌患者腹膜冲洗细胞学的预后意义:日本胰腺学会基于癌症登记的全国性研究。
Surgery. 2019 Dec;166(6):997-1003. doi: 10.1016/j.surg.2019.06.023. Epub 2019 Aug 21.
3
Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma.1297例胃癌患者术中灌洗用于细胞学检查
Am J Surg. 1999 Sep;178(3):256-62. doi: 10.1016/s0002-9610(99)00162-2.
4
Diagnostic and prognostic value of peritoneal cytology in biliary tract cancer.腹膜细胞学检查在胆道癌中的诊断及预后价值
Hepatogastroenterology. 2008 May-Jun;55(84):842-5.
5
Prognostic significance of peritoneal lavage cytology in gastric cancer in Singapore.新加坡胃癌患者腹腔灌洗细胞学检查的预后意义
Gastric Cancer. 2005;8(4):228-37. doi: 10.1007/s10120-005-0343-6.
6
Intraperitoneal exfoliated cancer cells in patients with colorectal cancer.结直肠癌患者的腹膜内脱落癌细胞。
Dis Colon Rectum. 1998 Sep;41(9):1134-40. doi: 10.1007/BF02239435.
7
Value of peritoneal cytology in potentially resectable pancreatic cancer.腹腔细胞学检查对潜在可切除胰腺癌的价值。
Br J Surg. 2013 Dec;100(13):1791-6. doi: 10.1002/bjs.9307.
8
Incidence and prognostic significance of positive peritoneal lavage in colorectal cancer.结直肠癌中阳性腹腔灌洗的发生率及预后意义
Surg Today. 2015 Sep;45(9):1073-81. doi: 10.1007/s00595-014-1066-2. Epub 2014 Nov 7.
9
Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail Cancer: A Retrospective Study.可切除胰体尾癌阳性腹膜灌洗液细胞学检查的预后影响:一项回顾性研究。
World J Surg. 2023 Mar;47(3):729-739. doi: 10.1007/s00268-022-06818-0. Epub 2022 Nov 10.
10
Risk factors for peritoneal dissemination of gastric cancer.胃癌腹膜播散的危险因素。
Minerva Chir. 2015 Apr;70(2):91-6.

引用本文的文献

1
Prognostic impact of peritoneal washing cytology in patients with biliary tract cancer.腹腔冲洗细胞学检查对胆道癌患者的预后影响。
Langenbecks Arch Surg. 2024 Jan 22;409(1):45. doi: 10.1007/s00423-024-03233-y.
2
Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail Cancer: A Retrospective Study.可切除胰体尾癌阳性腹膜灌洗液细胞学检查的预后影响:一项回顾性研究。
World J Surg. 2023 Mar;47(3):729-739. doi: 10.1007/s00268-022-06818-0. Epub 2022 Nov 10.
3
Conversion surgery following gemcitabine plus cisplatin therapy for initially unresectable gallbladder cancer with peritoneal carcinomatosis: a case report.

本文引用的文献

1
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial.吉西他滨联合 S-1 对比吉西他滨联合顺铂治疗晚期/复发性胆道癌:FUGA-BT(JCOG1113)随机 III 期临床试验。
Ann Oncol. 2019 Dec 1;30(12):1950-1958. doi: 10.1093/annonc/mdz402.
2
Role of staging laparoscopy for gastric cancer patients.分期腹腔镜检查在胃癌患者中的作用。
Ann Gastroenterol Surg. 2019 Aug 21;3(5):496-505. doi: 10.1002/ags3.12283. eCollection 2019 Sep.
3
Essential updates to the surgical treatment of biliary tract cancer.
吉西他滨联合顺铂治疗初始不可切除的伴腹膜转移的胆囊癌后的转化手术:病例报告
Surg Case Rep. 2022 Mar 25;8(1):50. doi: 10.1186/s40792-022-01406-9.
胆道癌手术治疗的重要更新。
Ann Gastroenterol Surg. 2019 May 22;3(4):378-389. doi: 10.1002/ags3.12266. eCollection 2019 Jul.
4
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.卡培他滨对比观察用于可切除胆管癌(BILCAP):一项随机、对照、多中心、3 期研究。
Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25.
5
Surgical management of carcinoma in situ at ductal resection margins in patients with extrahepatic cholangiocarcinoma.肝外胆管癌患者胆管切除切缘原位癌的外科治疗
Ann Gastroenterol Surg. 2018 Jul 26;2(5):359-366. doi: 10.1002/ags3.12196. eCollection 2018 Sep.
6
Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.细胞减灭术和 HIPEC 相较于姑息性化疗可改善伴腹膜转移的胆道癌患者的生存:来自 PSOGI 和 BIG RENAPE 团体的多机构队列研究。
Eur J Surg Oncol. 2018 Sep;44(9):1378-1383. doi: 10.1016/j.ejso.2018.04.023. Epub 2018 Jun 19.
7
Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center.纪念斯隆凯特琳癌症中心肝门部胆管癌的外科治疗
Ann Gastroenterol Surg. 2018 Jun 29;2(4):304-312. doi: 10.1002/ags3.12181. eCollection 2018 Jul.
8
A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT).一项关于辅助性S-1治疗与单纯观察在切除的胆管癌中对比的随机III期试验:日本临床肿瘤学组研究(JCOG1202,ASCOT)
Jpn J Clin Oncol. 2018 Apr 1;48(4):392-395. doi: 10.1093/jjco/hyy004.
9
Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis.腹腔灌洗细胞学检查对胃癌分期的预后意义:系统评价和荟萃分析。
Gastric Cancer. 2018 Jan;21(1):10-18. doi: 10.1007/s10120-017-0749-y. Epub 2017 Aug 4.
10
Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis.可切除胰腺癌中阳性腹腔细胞学检查的预后意义:一项系统评价和荟萃分析。
Oncotarget. 2017 Feb 28;8(9):15004-15013. doi: 10.18632/oncotarget.14745.